NxStage Medical (NSDQ:NXTM) was founded in 1999 on the premise that patients with chronic kidney disease would benefit from bringing hemodialysis out of the clinic and into their homes. Seventeen years later, NxStage founder & CEO Jeff Burbank’s hypothesis has proven out. His Lawrence, Mass.-based company is topping more than $300 million in annual sales and, more […]
Dialysis
Baxter, Satellite Healthcare ink dialysis deal
Baxter (NYSE:BAX) and Satellite Healthcare said today that they inked a deal to bring Baxter’s dialysis products into Satellite’s 80-site renal care network. Satellite, a non-profit group, is the 6th-largest dialysis and kidney disease treatment provider in the U.S. The 4-year deal will see Satellite deploy Baxter’s Amia automated peritoneal dialysis system and Revaclear dialyzer for high-flux hemodialysis. […]
Sunshine Heart pays $5m for Baxter’s Aquadex
UPDATED August 9, 2016, with 2nd-quarter results. Sunshine Heart (NSDQ:SSH) said today that it agreed to pay about $5 million for the Aquadex fluid filtration device Baxter (NYSE:BAX) acquired when it bought Gambro in 2013. The Aquadex device is designed to filter salt and water in patients with renal failure experiencing fluid overload. The deal calls for Eden Prairie, Minn.-based […]
Baxter wins Health Canada nod for Amia peritoneal dialysis system
Baxter (NYSE:BAX) said today that it won a nod north of the border for its Amia automated peritoneal dialysis system. The Health Canada approval makes Amia the 1st automated peritoneal dialysis device cleared in the U.S. and Canada that includes voice guidance, touchscreen control and 2-way telemedicine features, Deerfield Park, Ill.-based Baxter said. “As a leader in home […]
NxStage Medical jumps on Baxter’s exit from the home hemodialysis market
Share prices for NxStage Medical (NSDQ:NXTM) jumped this week after Baxter (NYSE:BAX) CEO Joe Almeida said the company is pulling the plug on its Vivia home hemodialysis device. Almeida, speaking at the Goldman Sachs investor conference June 7, said he evaluated the home dialysis market after he took over the corner office in October 2015. “That […]
Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter (NYSE:BAX) today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for treating chronic and acute renal failure. The study data was presented at the European Renal Association and European Dialysis and Transplant Association’s 53rd Congress this week. ”Regardless of where dialysis therapy is performed […]
Nikkiso enters U.S. dialysis market with DBB-06 device
Nikkiso (TYO:6376) said the medical division of its Nikkiso America business entered the U.S. hemodialysis market with its DBB-06 system, after winning 510(k) clearance from the FDA in March. Tokyo-based Nikkiso said the DBB-06 system uses its dialysis dose monitoring technology and a blood volume monitor designed to help evaluate and treat hydration status by continuously monitoring relative […]
FDA: B. Braun Dialog+ hemodialysis recall is Class I
B. Braun Medical is recalling its Dialog+ Hemodialysis systems due to an issue with defective conductivity sensors. The federal watchdog labeled the recall as a Class I, the most serious type of recall issued by the FDA, which indicates “there is a reasonable probability that use of these products will cause serious adverse health consequences […]
Fresenius rebrands dialysis division to Fresenius Kidney Care
Fresenius Medical Care (NYSE:FMS) said yesterday it rebranded its dialysis service division under the new name Fresenius Kidney Care. With the move, Waltham, Mass.-based said it launched a new website for the business which offers education on dialysis, treatment options and other tailored information for people in various stages of kidney disease, the company said. “We created this […]
Baxter launches trial for Vivia home hemodialysis system
Baxter (NYSE:BAX) said today that it’s launching a clinical trial of the Vivia home hemodialysis device it’s co-developing with famed inventor Dean Kamen’s DEKA Research & Development Corp. The Vivia system is designed to provide shorter but more frequent dialysis rounds than conventional dialysis. The device has already won CE Mark approval in the European Union for use with […]
Fresenius, plaintiffs ask for more time for $250m settlement in dialysate cases
Fresenius Medical Care (NYSE:FMS) and the plaintiffs in a spate of lawsuits brought over its GranuFlo and NaturaLyte dialysis drugs yesterday asked a federal judge in Massachusetts to stay the case so they can finalize their $250 million settlement deal. The deal, brokered with a committee of plaintiffs’ representatives, requires that 97% of all patients who brought lawsuits sign […]